NCT07510334 2026-04-03VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell CarcinomaMayo ClinicPhase 2 Not yet recruiting18 enrolled